Skip to content
No picture yet

Zytiga 250 mg – DIN 02371065

Zytiga is Abiraterone Acetate 250 mg (tablet), sold in Canada. It is used for castration-resistant prostatic neoplasms. It is supplied by Janssen Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Abiraterone Acetate 250 mg

Brand
Zytiga
Strength
250 mg
Used for
Castration-resistant prostatic neoplasms
Form
Tablet
Manufacturer
Janssen Inc
Drug class
Cytochrome p450 17a1 inhibitor
Sold in
Canada
DIN
02371065

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Abiraterone Acetate pills and guides

What is Abiraterone Acetate used for?

Abiraterone Acetate is used for castration-resistant prostatic neoplasms.

Medicine type
Cytochrome p450 17a1 inhibitor
Official uses from the US prescribing label

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with

  • Metastatic castration-resistant prostate cancer (CRPC)
  • Metastatic high-risk castration-sensitive prostate cancer (CSPC)

From the FDA-approved label on DailyMed (published Sep 07, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02371065.
  • It names Zytiga, Abiraterone Acetate 250 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Zytiga by Janssen Inc.

In Canada: prescription only.

Ingredients

Active: Abiraterone Acetate

Other Abiraterone Acetate pills